GlassScriptPhysician profile
Jacob A Thayer
NPI 1326499930
$6,354.51
in general payments reported to CMS, 2019-2025
11 companies · $630 in 2025
The $630 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $716 · 2020: $84.45 · 2022: $1,341 · 2023: $2,162 · 2024: $1,421 · 2025: $630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,924 · Food and Beverage: $964 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,923.67 |
| Food and Beverage | $964.41 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,710.20 | 2023-2025 | Strattice Reconstructive Tissue Matrix Bps, Natrelle Saline-Filled Breast Implants |
| Wardlow Enterprises | $1,585.00 | 2019-2022 | |
| Integra Lifesciences Corporation | $437.83 | 2023-2025 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Allergan, INC. | $283.59 | 2019-2022 | |
| Mentor Worldwide LLC | $131.62 | 2019 | |
| Checkpoint Surgical, INC | $73.98 | 2019 | |
| Motiva USA, LLC | $47.13 | 2025 | |
| Endo Pharmaceuticals INC. | $35.66 | 2020 | |
| Depuy Synthes Sales INC. | $18.99 | 2020 | |
| Polynovo North America LLC | $18.72 | 2024 | Novosorb Btm |
| Tela Bio, INC. | $11.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Thayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.